From: Mut2Vec: distributed representation of cancerous mutations
KEGG PATHWAY | Adjusted p-value | Overlap | Cluster size |
---|---|---|---|
Neuroactive ligand-receptor interaction | 2.22e-63 | 47/277 | 85 |
Chemical carcinogenesis | 9.37e-52 | 26/82 | 38 |
Cytokine-cytokine receptor interaction | 2.48e-46 | 36/265 | 72 |
Metabolic pathways | 1.80e-45 | 58/1239 | 89 |
Ribosome | 4.50e-40 | 27/265 | 35 |
Cell cycle | 5.55e-37 | 24/137 | 37 |
Endocytosis | 6.75e-34 | 25/277 | 32 |
Complement and coagulation cascades | 8.25e-33 | 21/124 | 35 |
Fanconi anemia pathway | 6.41e-28 | 36/259 | 146 |
Systemic lupus erythematosus | 4.26e-27 | 19/265 | 20 |